Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer.

Niu, Mengke; Liu, Yiming; Yi, Ming; Jiao, Dechao; Wu, Kongming

Niu, Mengke; Liu, Yiming; Yi, Ming; Jiao, Dechao; Wu, Kongming.

Afiliación

Niu M; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu Y; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yi M; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jiao D; Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wu K; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Front Immunol ; 13: 827921, 2022.

Article en En | MEDLINE | ID: mdl-35386715

Asunto(s)

Neoplasias; Receptor de Muerte Celular Programada 1; Antígeno B7-H1/metabolismo; Humanos; Inmunoterapia/métodos; Neoplasias/terapia; Pronóstico

Palabras clave

biological activity; cancer; efficacy prediction; exosomal PD-L1; immunotherapy; prognosis; soluble PD-1; soluble PD-L1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google